Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Circulating Cell-Free DNA Profiling Predicts the Therapeutic Outcome in Advanced Hepatocellular Carcinoma Patients Treated with Combination Immunotherapy.
Matsumae T, Kodama T, Myojin Y, Maesaka K, Sakamori R, Takuwa A, Oku K, Motooka D, Sawai Y, Oshita M, Nakabori T, Ohkawa K, Miyazaki M, Tanaka S, Mita E, Tawara S, Yakushijin T, Nozaki Y, Hagiwara H, Tahata Y, Yamada R, Hikita H, Tatsumi T, Takehara T. Matsumae T, et al. Cancers (Basel). 2022 Jul 11;14(14):3367. doi: 10.3390/cancers14143367. Cancers (Basel). 2022. PMID: 35884434 Free PMC article.
Interleukin-6 Is a Circulating Prognostic Biomarker for Hepatocellular Carcinoma Patients Treated with Combined Immunotherapy.
Myojin Y, Kodama T, Sakamori R, Maesaka K, Matsumae T, Sawai Y, Imai Y, Ohkawa K, Miyazaki M, Tanaka S, Mita E, Tawara S, Yakushijin T, Nozaki Y, Hagiwara H, Tahata Y, Yamada R, Hikita H, Tatsumi T, Takehara T. Myojin Y, et al. Among authors: matsumae t. Cancers (Basel). 2022 Feb 10;14(4):883. doi: 10.3390/cancers14040883. Cancers (Basel). 2022. PMID: 35205631 Free PMC article.
Thrombospondin-2 as a Predictive Biomarker for Hepatocellular Carcinoma after Hepatitis C Virus Elimination by Direct-Acting Antiviral.
Matsumae T, Kodama T, Tahata Y, Myojin Y, Doi A, Nishio A, Yamada R, Nozaki Y, Oshita M, Hiramatsu N, Morishita N, Ohkawa K, Hijioka T, Sakakibara M, Doi Y, Kakita N, Yakushijin T, Sakamori R, Hikita H, Tatsumi T, Takehara T. Matsumae T, et al. Cancers (Basel). 2023 Jan 11;15(2):463. doi: 10.3390/cancers15020463. Cancers (Basel). 2023. PMID: 36672412 Free PMC article.
Regnase-1 downregulation promotes pancreatic cancer through myeloid-derived suppressor cell-mediated evasion of anticancer immunity.
Okabe J, Kodama T, Sato Y, Shigeno S, Matsumae T, Daiku K, Sato K, Yoshioka T, Shigekawa M, Higashiguchi M, Kobayashi S, Hikita H, Tatsumi T, Okamoto T, Satoh T, Eguchi H, Akira S, Takehara T. Okabe J, et al. Among authors: matsumae t. J Exp Clin Cancer Res. 2023 Oct 9;42(1):262. doi: 10.1186/s13046-023-02831-w. J Exp Clin Cancer Res. 2023. PMID: 37814340 Free PMC article.
The relationship between observation interval and prognosis in pancreatic cancer concomitant with intraductal papillary mucinous neoplasia.
Yoshioka T, Shigekawa M, Ikezawa K, Hirao M, Ishii S, Suda T, Kegasawa T, Matsumoto K, Iwahashi K, Murata J, Kaneko A, Nakazuru S, Yamamoto S, Matsumae T, Kozumi K, Sato Y, Okabe J, Sato K, Hikita H, Sakamori R, Tatsumi T, Takehara T. Yoshioka T, et al. Among authors: matsumae t. Pancreatology. 2024 Feb;24(1):73-77. doi: 10.1016/j.pan.2023.11.005. Epub 2023 Nov 18. Pancreatology. 2024. PMID: 37996267
Underwater endoscopic mucosal resection: a new endoscopic method for resection of rectal neuroendocrine tumor grade 1 (carcinoid) ≤ 10 mm in diameter.
Yamashina T, Tumura T, Maruo T, Matsumae T, Yoshida H, Tanke G, Taki M, Fukuhara M, Kimura Y, Sakamoto A, Henmi S, Sawai Y, Saito S, Nishijima N, Nasu A, Komekado H, Asada M, Kita R, Kimura T, Osaki Y. Yamashina T, et al. Among authors: matsumae t. Endosc Int Open. 2018 Jan;6(1):E111-E114. doi: 10.1055/s-0043-123467. Epub 2018 Jan 16. Endosc Int Open. 2018. PMID: 29344571 Free PMC article.
37 results